The present study indicated that WRH-2412 has an antitumor effects and may suppress HCC development via inhibition of the TGF-β/β-catenin/α-SMA pathway axis, which may suppress vascular invasion markers. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.